Large cap stocks start to struggle – is it time for investors to reassess their focus?
Buying quality large caps worked very well last decade. A more volatile world will be a bigger challenge for these star stocks, says Cris Sholto Heaton


One of the best strategies during the last market regime was to buy quality large caps, as epitomised by Terry Smith. Quality is rather a flexible concept in investment – most people prefer to say they hold good businesses rather than trash – but broadly this meant companies with high return on equity, low leverage, and steady earnings that produce reliable cash flows and strong global growth prospects.
A decade ago, quality investors favoured areas such as consumer staples – often developed-market firms with exposure to emerging markets. Later, some of these stocks started to struggle amid slower emerging-market growth and the return of inflation after the pandemic, while the tech sector began to lead markets. So quality investors shifted a little towards software or data services, where the best businesses have steady recurring revenue, low capital intensity and the ability to lock in loyal customers.
Still, relatively few quality investors were drawn to Nvidia (semiconductors have always been a cyclical sector) and certainly not to firms such as Tesla. Since these stocks have had a huge influence over the last few years, quality has been unable to outstrip the market as easily as it did before the pandemic and many funds with this approach are doing less well.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
A changing portfolio
You can see these shifts play out in Fundsmith’s history. In February 2015, the fund had 40% in consumer staples, by far its largest position. By February 2020, technology was the top sector at 29%, slightly ahead of consumer staples. Then last month, it held 32% in health care, with 20% in consumer staples. Fundsmith has been more flexible than some other quality strategies and the steady move into healthcare could help performance rebound if tech is reaching a peak.
However, the tricky question for quality large-cap strategies – not just Fundsmith – is whether the entire approach faces a much tougher environment. The last era was hugely favourable for large multinationals. Globalisation gave them the chance to expand into new markets around the world, while politicians and regulators were often very relaxed about waving through cross-border mergers and acquisitions. Big companies grew ever bigger and more profitable.
There are compelling reasons to think this may be over. In the short term, tariffs will mostly hurt firms that ship goods across borders, rather than services. But in the longer term, fragmentation and antagonism create a more hostile world for multinationals. The US slaps more tariffs on European goods. Europe cranks up regulation on US tech giants. The US strikes back against European firms… and so on in a vicious circle.
If this happens, the obvious conclusion is to favour local over multinational (and small over large). I don’t think that outcome is certain, and this volatile market is not the time to rotate out of large global defensives into small caps. However, investors should be alert over the next few years for signs that the trend has changed and quality large caps may no longer be a stand-out strategy.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
Rachel Reeves faces £23 billion capital gains tax “black hole” – will she be forced to look elsewhere?
The fiscal watchdog has downgraded its forecast for capital gains tax revenues, leaving chancellor Rachel Reeves with £23 billion less than previously expected
By Katie Williams Published
-
Protests erupt in Turkey after the arrest of Erdogan's rival
Turkey's president has jailed his main political opponent, Ekrem Imamoglu
By Emily Hohler Published
-
How to generate income with fixed-interest investments
Public debt is overvalued, but other fixed-interest investments now look like a bargain, says Max King
By Max King Published
-
Three top-notch Taiwanese companies cashing in on the advent of AI
Opinion Eric Chan, investment director and co-manager of the Aberdeen Asian Income Fund, highlights three potential Taiwanese winners in the technology industry
By Eric Chan Published
-
Weight-loss drugs could revolutionise the economy – the investments to buy now
The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with food and revolutionise the economy
By Dr Matthew Partridge Published
-
Find tomorrow’s Asian giants while they are still smaller companies
Opinion Nitin Bajaj, portfolio manager of the Fidelity Asian Values trust, picks three Asian companies to invest in.
By Nitin Bajaj Published
-
AI will maintain Moody’s market lead, says Stephen Connolly
Opinion Veteran data provider Moody's has adapted well to the modern world, and is one of Warren Buffett’s longest-held investments
By Stephen Connolly Published
-
Is BlackRock World Mining gearing for a recovery?
Opinion After a frustrating year, BlackRock World Mining is positioned for growth and to capitalise on the sector's recovery
By Rupert Hargreaves Published
-
Should you limit exposure to US tech stocks?
An end to the AI boom would shake both US funds and global trackers. Here’s one way to trim exposure to US tech stocks
By Cris Sholto Heaton Published
-
The mystery of America’s gold and why an audit matters
How much gold does the US actually have? Dominic Frisby explains why it matters
By Dominic Frisby Published